Cargando…
Correction to “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance”
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450869/ https://www.ncbi.nlm.nih.gov/pubmed/37637725 http://dx.doi.org/10.1021/acscentsci.3c00920 |
| _version_ | 1785095292980297728 |
|---|---|
| author | Kalathil, Akil A. Guin, Subham Ashokan, Akash Basu, Uttara Surnar, Bapurao Delma, Katiana S. Lima, Leonor M. Kryvenko, Oleksandr N. Dhar, Shanta |
| author_facet | Kalathil, Akil A. Guin, Subham Ashokan, Akash Basu, Uttara Surnar, Bapurao Delma, Katiana S. Lima, Leonor M. Kryvenko, Oleksandr N. Dhar, Shanta |
| author_sort | Kalathil, Akil A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10450869 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Chemical
Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104508692023-08-26 Correction to “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance” Kalathil, Akil A. Guin, Subham Ashokan, Akash Basu, Uttara Surnar, Bapurao Delma, Katiana S. Lima, Leonor M. Kryvenko, Oleksandr N. Dhar, Shanta ACS Cent Sci American Chemical Society 2023-08-08 /pmc/articles/PMC10450869/ /pubmed/37637725 http://dx.doi.org/10.1021/acscentsci.3c00920 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Kalathil, Akil A. Guin, Subham Ashokan, Akash Basu, Uttara Surnar, Bapurao Delma, Katiana S. Lima, Leonor M. Kryvenko, Oleksandr N. Dhar, Shanta Correction to “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance” |
| title | Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance” |
| title_full | Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance” |
| title_fullStr | Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance” |
| title_full_unstemmed | Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance” |
| title_short | Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance” |
| title_sort | correction to
“new pathway for cisplatin prodrug
to utilize metabolic substrate preference to overcome cancer intrinsic
resistance” |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450869/ https://www.ncbi.nlm.nih.gov/pubmed/37637725 http://dx.doi.org/10.1021/acscentsci.3c00920 |
| work_keys_str_mv | AT kalathilakila correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT guinsubham correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT ashokanakash correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT basuuttara correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT surnarbapurao correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT delmakatianas correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT limaleonorm correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT kryvenkooleksandrn correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance AT dharshanta correctiontonewpathwayforcisplatinprodrugtoutilizemetabolicsubstratepreferencetoovercomecancerintrinsicresistance |